These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18798614)

  • 1. Toward a prostate specific antigen-based prostate cancer diagnostic assay: preparation of keyhole limpet hemocyanin-conjugated normal and transformed prostate specific antigen fragments.
    Dudkin VY; Miller JS; Dudkina AS; Antczak C; Scheinberg DA; Danishefsky SJ
    J Am Chem Soc; 2008 Oct; 130(41):13598-607. PubMed ID: 18798614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thomsen-Friedenreich (TF) antigen as a target for prostate cancer vaccine: clinical trial results with TF cluster (c)-KLH plus QS21 conjugate vaccine in patients with biochemically relapsed prostate cancer.
    Slovin SF; Ragupathi G; Musselli C; Fernandez C; Diani M; Verbel D; Danishefsky S; Livingston P; Scher HI
    Cancer Immunol Immunother; 2005 Jul; 54(7):694-702. PubMed ID: 15726361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structure of human prostate-specific antigen in a sandwich antibody complex.
    Stura EA; Muller BH; Bossus M; Michel S; Jolivet-Reynaud C; Ducancel F
    J Mol Biol; 2011 Dec; 414(4):530-44. PubMed ID: 22037582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical synthesis of normal and transformed PSA glycopeptides.
    Dudkin VY; Miller JS; Danishefsky SJ
    J Am Chem Soc; 2004 Jan; 126(3):736-8. PubMed ID: 14733546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of glycosylation of prostate-specific antigen secreted by cancer tissue-originated spheroids reveals new candidates for prostate cancer detection.
    Ideo H; Kondo J; Nomura T; Nonomura N; Inoue M; Amano J
    Sci Rep; 2020 Feb; 10(1):2708. PubMed ID: 32066783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fully synthetic carbohydrate-based vaccines in biochemically relapsed prostate cancer: clinical trial results with alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine.
    Slovin SF; Ragupathi G; Musselli C; Olkiewicz K; Verbel D; Kuduk SD; Schwarz JB; Sames D; Danishefsky S; Livingston PO; Scher HI
    J Clin Oncol; 2003 Dec; 21(23):4292-8. PubMed ID: 14645418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific and efficient peptide substrates for assaying the proteolytic activity of prostate-specific antigen.
    Denmeade SR; Lou W; Lövgren J; Malm J; Lilja H; Isaacs JT
    Cancer Res; 1997 Nov; 57(21):4924-30. PubMed ID: 9354459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous analysis of glycosylated and sialylated prostate-specific antigen revealing differential distribution of glycosylated prostate-specific antigen isoforms in prostate cancer tissues.
    Li Y; Tian Y; Rezai T; Prakash A; Lopez MF; Chan DW; Zhang H
    Anal Chem; 2011 Jan; 83(1):240-5. PubMed ID: 21141837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody immunoglobulin G (IgG) against human prostatic specific antigen (PSA) as a carrier protein for chemotherapeutic drugs to human prostate tumors: Part 1. A double immunofluorescence analysis.
    Sinha AA; Sackrison JL; DeLeon OF; Wilson MJ; Gleason DF
    Anat Rec; 1996 Aug; 245(4):652-61. PubMed ID: 8837723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum concentrations of prostate-specific antigen measured using immune extraction, trypsin digestion, and tandem mass spectrometry quantification of LSEPAELTDAVK peptide.
    Klee EW; Bondar OP; Goodmanson MK; Trushin SA; Bergstralh EJ; Singh RJ; Anderson NL; Klee GG
    Arch Pathol Lab Med; 2014 Oct; 138(10):1381-6. PubMed ID: 25268201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A polyvalent vaccine for high-risk prostate patients: "are more antigens better?".
    Slovin SF; Ragupathi G; Fernandez C; Diani M; Jefferson MP; Wilton A; Kelly WK; Morris M; Solit D; Clausen H; Livingston P; Scher HI
    Cancer Immunol Immunother; 2007 Dec; 56(12):1921-30. PubMed ID: 17619878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins.
    Peracaula R; Tabarés G; Royle L; Harvey DJ; Dwek RA; Rudd PM; de Llorens R
    Glycobiology; 2003 Jun; 13(6):457-70. PubMed ID: 12626390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope mapping of prostate-specific antigen with monoclonal antibodies.
    Jette DC; Kreutz FT; Malcolm BA; Wishart DS; Noujaim AA; Suresh MR
    Clin Chem; 1996 Dec; 42(12):1961-9. PubMed ID: 8969633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors.
    Keding SJ; Danishefsky SJ
    Proc Natl Acad Sci U S A; 2004 Aug; 101(33):11937-42. PubMed ID: 15280546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific immunization using keyhole limpet hemocyanin-ganglioside conjugates.
    Jennemann R; Gnewuch C; Bosslet S; Bauer BL; Wiegandt H
    J Biochem; 1994 Jun; 115(6):1047-52. PubMed ID: 7982880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbohydrate structure and differential binding of prostate specific antigen to Maackia amurensis lectin between prostate cancer and benign prostate hypertrophy.
    Ohyama C; Hosono M; Nitta K; Oh-eda M; Yoshikawa K; Habuchi T; Arai Y; Fukuda M
    Glycobiology; 2004 Aug; 14(8):671-9. PubMed ID: 15044396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen-derived epitopes capable of inducing cellular and humoral responses in HLA-A24+ prostate cancer patients.
    Harada M; Kobayashi K; Matsueda S; Nakagawa M; Noguchi M; Itoh K
    Prostate; 2003 Oct; 57(2):152-9. PubMed ID: 12949939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of human cytotoxic T lymphocytes specific for prostate-specific antigen.
    Xue BH; Zhang Y; Sosman JA; Peace DJ
    Prostate; 1997 Feb; 30(2):73-8. PubMed ID: 9051144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro generation of human cytotoxic T lymphocytes specific for peptides derived from prostate-specific antigen.
    Correale P; Walmsley K; Nieroda C; Zaremba S; Zhu M; Schlom J; Tsang KY
    J Natl Cancer Inst; 1997 Feb; 89(4):293-300. PubMed ID: 9048833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keyhole limpet hemocyanin: structural and functional characterization of two different subunits and multimers.
    Swerdlow RD; Ebert RF; Lee P; Bonaventura C; Miller KI
    Comp Biochem Physiol B Biochem Mol Biol; 1996 Mar; 113(3):537-48. PubMed ID: 8829804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.